[The frequency of cancer in France: all ages and under age 15, mortality in 2003 and trends since 1968].

Abstract:

:In 2003, there was 147,000 deaths attributed to cancer in France, 88,000 in men and 59,000 in women. Cancer mortality rates have been decreasing since 1987 in the male population and since the late 60's in the female population, the decrease is larger for the male population. This decrease is observed for most sites of cancer at least in recent years, however lung and bladder cancer mortality are increasing in the female population, pancreatic and skin cancer mortality are increasing both for men and for women, and myeloma is more or less stable. Among children aged 0 to 14, the incidence of cancer is stable and the mortality is decreasing markedly, the decrease being largest for leukaemia and lymphoma because of chemotherapy.

journal_name

Bull Cancer

journal_title

Bulletin du cancer

authors

Hill C,Doyon F

subject

Has Abstract

pub_date

2007-01-01 00:00:00

pages

7-13

issue

1

eissn

0007-4551

issn

1769-6917

journal_volume

94

pub_type

杂志文章
  • [Nasopharyngeal epitheliomas: experience of the Regional Cancer Control Center in Lille (79 cases 1970-1982)].

    abstract::From 1970 to 1982, 79 cases of nasopharyngeal carcinomas were treated at the Regional Cancer Center of Lille (France). At the term of the study, it appears that patients of Central Europe origin have a rather high risk of NPC (17% of cases, that ethnic population representing about 8% of all superior aerodigestive tra...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章

    doi:

    authors: Lefebvre JL,Madelain M,Adenis L,Demaille MC,Delobelle A,Demaille A

    更新日期:1983-01-01 00:00:00

  • [Use of maintenance therapy and complete discontinuation for therapeutic management of non-resectable metastatic colorectal cancer].

    abstract::Management of unresectable metastatic colorectal cancer dramatically changed over the past 20 years. News standards of care combine cytotoxic drugs like fluoropyrimidines, irinotecan and oxaliplatin, with targeted therapies such as anti-EGFR monoclonal antibodies and anti-angiogenic agents. Survival benefit results fr...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章,评审

    doi:10.1684/bdc.2014.1984

    authors: Senellart H,Hiret S,Guerin-Meyer V,Bennouna J

    更新日期:2014-06-01 00:00:00

  • [Multiple brain metastases after breast cancer and their radiotherapy management: what is the optimal treatment?].

    abstract::Whole brain radiotherapy remains standard in the management of breast cancer patients with brain metastases. It allows for symptomatic improvement and good local control in most patients. However, its results remain suboptimal in terms of both efficacy and toxicity. In highly selected patients, stereotactic radiothera...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章,评审

    doi:10.1684/bdc.2011.1335

    authors: Kirova YM,Chargari C,Mazeron JJ

    更新日期:2011-04-01 00:00:00

  • [Understanding positon emission tomography (PET) with [18F]-FDG in clinical oncology. Informations dedicated to patients and relatives].

    abstract::In response to the evolution of the information-seeking behaviour of patients and concerns from health professionals regarding cancer patient information, the French National Federation of Comprehensive Cancer Centres (FNCLCC) introduced, in 1998, an information and education program dedicated to patients and relative...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章,病人教育讲义

    doi:

    authors: Bourguet P,Brusco S,Corone C,Devillers A,Foehrenbach H,Lumbroso JD,Maszelin P,Montravers F,Moretti JL,Rain JD,Talbot JN,Carretier J,Leichtnam-Dugarin L,Delavigne V,Philip T,Fervers B,Fédération nationale des centres de lu

    更新日期:2005-07-01 00:00:00

  • [Experimental program personalized care in patients with head and neck cancer].

    abstract:OBJECTIVE:Describe the implementation and preliminary results of the “Experimental Program Personalized care” in patients with Head and Neck cancer. MATERIALS AND METHODS:After being selected a graduate nurse status, called coordination, participated in the development of forms of detection needs and concerns of patie...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章

    doi:10.1684/bdc.2014.2040

    authors: Hans S,Scotte F,Hoffman C,Pelicier N,Ménard M,Badoual C,Oudard S,Housset M,Brasnu D

    更新日期:2014-10-01 00:00:00

  • [New molecular classification of colorectal cancer, pancreatic cancer and stomach cancer: Towards "à la carte" treatment?].

    abstract::This review reports 3 of recently published molecular classifications of the 3 main gastro-intestinal cancers: gastric, pancreatic and colorectal adenocarcinoma. In colorectal adenocarcinoma, 6 independent classifications were combined to finally hold 4 molecular sub-groups, Consensus Molecular Subtypes (CMS 1-4), lin...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章,评审

    doi:10.1016/j.bulcan.2016.05.007

    authors: Dreyer C,Afchain P,Trouilloud I,André T

    更新日期:2016-07-01 00:00:00

  • [Rare cancers and new radiotherapy techniques].

    abstract::Rare cancers represent about a quarter of all cancers diagnosed in Europe, and their incidence is increasing. Meanwhile, scientific advances provide techniques, which become more and more sophisticated in the domain of radiotherapy. Treatment options for radiotherapy rare cancers are increasing, but are not yet evalua...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章

    doi:10.1016/j.bulcan.2014.12.001

    authors: Espenel S,Trone JC,Vallard A,Guy JB,Moriceau G,Méry B,Langrand-Escure J,Rivoirard R,de Laroche G,Chargari C,Magné N

    更新日期:2015-01-01 00:00:00

  • [Carcinoembryonic antigen in carcinoma of the uterine cervix (author's transl)].

    abstract::The authors analyse 123 cases of carcinoma of the uterine cervix treated by radiotherapy, with CEA radio-immuno-assay performed before treatment then each time patients are seen in follow-up. The CEA level is positive in 35 per cent of the cases with a mean value of 21 per cent for stage I, 36 per cent for stage II an...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章

    doi:

    authors: Bolla M,Vrousos C,Horiot JC,Bordes M,Le Dorze C

    更新日期:1979-01-01 00:00:00

  • Nouvelles perspectives dans l’immunothérapie des cancers.

    abstract:NOVEL PERSPECTIVES IN CANCER IMMUNOTHERAPIES:Š. ...

    journal_title:Bulletin du cancer

    pub_type: 社论

    doi:10.1016/S0007-4551(18)30384-9

    authors: Caux C,Bay JO

    更新日期:2018-12-01 00:00:00

  • [Checkpoint inhibitors-induced hypophysitis].

    abstract::Checkpoint inhibitors immunotherapy is more and more prescribed in oncology, causing new immune related endocrine adverse events. Hypophysitis occurs in approximately 10 % of patients treated with anti-CTLA4. It occurs two to three months after initiation of the immunotherapy. The initial presentation is characterized...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章,评审

    doi:10.1016/j.bulcan.2020.01.012

    authors: du Payrat JA,Cugnet-Anceau C,Maillet D,Levy M,Raverot G,Disse E,Borson-Chazot F

    更新日期:2020-04-01 00:00:00

  • [Announcing cancer diagnosis: which communication difficulties from professional and from patient's side? Which possible improvements?].

    abstract::Announcing a cancer diagnosis, but also a relapse, a progression of the disease, or transition towards palliative care constitute particularly difficult communication issues for the patient as well as for the clinician, during the trajectory of care. The objectives of this article is to present the clinical stakes of ...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章

    doi:10.1684/bdc.2010.1197

    authors: Dolbeault S,Brédart A

    更新日期:2010-10-01 00:00:00

  • First-line simplified GEMOX (S-GemOx) versus classical GEMOX in metastatic pancreatic cancer (MPA): results of a GERCOR randomized phase II study.

    abstract:PURPOSE:GemOx was defined as a D1-D2 schedule, based on preclinical data. In order to improve convenience for patients, we evaluated a simplified D1-D1 GemOx regimen (S-GemOx) in MPA. PATIENTS AND METHODS:Patients (pts) with MPA were 2:1 randomly assigned for first-line treatment to S-GemOx (gemcitabine 1,000 mg/m(2),...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章,随机对照试验

    doi:10.1684/bdc.2009.0871

    authors: Afchain P,Chibaudel B,Lledo G,Selle F,Bengrine-Lefevre L,Nguyen S,Paitel JF,Mineur L,Artru P,André T,Louvet C

    更新日期:2009-05-01 00:00:00

  • [Cell adhesion molecules: expression and function in acute myeloid leukemia].

    abstract::Adhesion molecules play a major role in the regulation of normal hematopoiesis. Precursor/cell matrix/endothelial interactions determine retainment or release of hematopoietic cells from the bone marrow microenvironment. Consequently, changes in the affinity or quantitative expression of adhesion molecules on either t...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章,评审

    doi:

    authors: Thomas X,Anglaret B

    更新日期:1999-03-01 00:00:00

  • [Cellular immunotherapy: complexity of immune system and industrial development].

    abstract::Cell immunotherapy aims at treating patients by stimulating their own immune system using appropriate cells. This approach is one of the most promising therapeutic strategy against cancer. The use of cells, the mobilization of a system, the targeting of interactions between the immune system and the tumor constitute t...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章,评审

    doi:

    authors: Abastado JP

    更新日期:2003-08-01 00:00:00

  • [What's new in the treatment of cancer pain?].

    abstract::Improvements have been made recently in the treatment of cancer pain. First of all, this symptom is better recognized and evaluated in cancer patients. Then new therapeutic options have became available in France : tramadol, WHO level II analgesic, for intermediate to severe pain; gabapentine, a new anticonvulsivant d...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章,评审

    doi:

    authors: Di Palma M,Poulain P,Pichard E

    更新日期:2004-01-01 00:00:00

  • [Role of the epithelial-mesenchymal transition during tumor progression].

    abstract::The epithelial-mesenchymal transition (EMT) is a morphogenetic program that converts epithelial into mesenchymal cells during the embryonic development. This mechanism is frequently reactivated during tumor progression and provides cells with motility and invasive capabilities favoring the metastatic dissemination fro...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章

    doi:10.1684/bdc.2009.1025

    authors: Ansieau S,Caron de Fromentel C,Bastid J,Morel AP,Puisieux A

    更新日期:2010-01-01 00:00:00

  • [The Stockholm preoperative radiotherapy of operable breast cancer. Preliminary report].

    abstract::The 4 year results of a prospective clinical trial on the treatment of operable breast cancer, comparing the effects of preoperative radiotherapy followed by surgery with those of surgery followed or not by postoperative radiotherapy are presented for patient groups of approximately 100 each. At 4 years 85 per cent su...

    journal_title:Bulletin du cancer

    pub_type: 临床试验,杂志文章,随机对照试验

    doi:

    authors: Wallgren A,de Schryver A,Wasserman J

    更新日期:1977-01-01 00:00:00

  • [Treatment of peritoneal carcinomatosis with surgery and hyperthermic peroperative intraperitoneal chemotherapy (HIPEC): new aspects and validated indications].

    abstract::Hyperthermic intraoperative intraperitoneal chemotherapy (HIPEC) is now an entire part of treatment of peritoneal dissemination of colorectal malignancy, and it's possible to hope prolonged survival. This treatment is more and more codified. Four indications are recognized by some tree national evaluation committees: ...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章,评审

    doi:10.1684/bdc.2008.0553

    authors: Eveno C,Dagois S,Guillot E,Gornet JM,Pocard M

    更新日期:2008-01-01 00:00:00

  • [Juvenile nasopharyngeal carcinoma: anatomoclinic, biologic, therapeutic and evolutive aspects].

    abstract::Nasopharyngeal carcinoma (NPC) represents one of the most frequent epithelial tumours of the child in intermediate risk regions. In the Maghreb, it represents the first cancer of teenagers of 15-20 years old. The Epstein Barr virus (EBV) is the most important etiologic factor. Its role in the pathogeneses of NPC has b...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章

    doi:10.1684/bdc.2010.1087

    authors: Toumi N,Frikha M,Siala W,Khabir A,Karray H,Boudawara T,Gargouri RM,Ghorbel M,Daoud J

    更新日期:2010-04-01 00:00:00

  • [Treatment with cytokines of metastatic kidney cancer: the Lyon experience].

    abstract::Between October 1987 and June 1992, 244 patients with metastatic renal carcinoma were referred to our Institute. One hundred and sixty-nine were included in immunotherapy protocols. The 40 most recent patients were included in the ongoing multicentric randomised Crecy study. The previous patients were treated with IL2...

    journal_title:Bulletin du cancer

    pub_type: 临床试验,杂志文章,随机对照试验

    doi:

    authors: Négrier S,Mercatello A,Coronel B,Lanier F,Merrouche Y,Bret M,Blay JY,Lasset C,Thiesse P,Carrie C

    更新日期:1993-07-01 00:00:00

  • Is the proportion of hypoxic cells in a solid tumour dependent on the host (mouse or rat)?

    abstract::Hypoxic cell fraction was measured in a human tumour xenografted on two different animal species: mouse and rat. These results suggest that, while the Na11 tumour response to radiation depends on the host (nude mouse, nude rat), the proportion of hypoxic cells tested with the growth delay assay is independent of the h...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章

    doi:

    authors: Guichard M,Chavaudra N,Malaise EP

    更新日期:1989-01-01 00:00:00

  • [Update on docetaxel and breast cancer].

    abstract::Docetaxel (Taxotère) has been developed in breast cancer during the last decade. First its activity in monotherapy was proven in metastatic setting after failure of anthracycline therapy. Then the association with anthracycline demonstrated substantial activity leading to its development in early stages of breast canc...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章,评审

    doi:

    authors: Diéras V,Girre V,Pierga JY,Laurence V,Piperno-Neumann S,Pouillart P

    更新日期:2004-05-01 00:00:00

  • [Low dose cytarabine in the treatment of acute myeloid leukemia. Apropos of 41 cases].

    abstract::This is a retrospective study on the use of cytarabine at low doses in acute myeloid leukemias in 41 patients. Four groups of AML are included: group A: 19 cases of de novo AML in elderly patients; group B: ten cases of AML in relapse; group C: five cases of AML refractory to previous treatment and group D: seven case...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章,评审

    doi:

    authors: Frikha M,Elloumi M,Bouaziz M,Daoud J,Mseddi S,Khanfir A,Gargouri J,Souissi T

    更新日期:1996-12-01 00:00:00

  • [Interest of studying the in vitro genotoxicity of an antineoplastic drug on healthy human cells: paclitaxel example].

    abstract::Paclitaxel is often used as an adjuvant antineoplastic agent. However, very little data is available in literature on its potential genotoxicity on healthy human cells. Our objective is to study the potential in vitro genotoxicity of paclitaxel, by using the cytokinesis-blocked micronucleus assay in combination with f...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章

    doi:

    authors: Digue L,Orsière T,Baciuchka-Palmaro M,Duffaud F,Pompili J,Favre R,Botta A

    更新日期:2002-10-01 00:00:00

  • Assessment of diagnostic tests.

    abstract::An increasing number of clinicians is to day aware of the need to assess their diagnostic tools. Despite the fact that monetary value is only one of the components of the cost of a diagnostic test, economical problems are decisive stimuli for such an effort. Any diagnostic test involves a cost which is borne by the pa...

    journal_title:Bulletin du cancer

    pub_type: 临床试验,杂志文章

    doi:

    authors: Alperovitch A

    更新日期:1980-01-01 00:00:00

  • Biochemical aspects of chemical carcinogenesis.

    abstract::This article briefly outlines three major biochemical problems in relation to the presence of chemical carcinogens in mammalian cells: (a) the enzymatic systems responsible for the chemical carcinogen metabolism; (b) the nature of the reactive metabolites and (c) the cellular target(s). References and examples are onl...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章

    doi:

    authors: Gielen JE

    更新日期:1978-01-01 00:00:00

  • Primary signet ring cell carcinoma of the colon and rectum.

    abstract::Colorectal primary signet ring cell carcinoma (SRCC) is a rare entity accounting for nearly 1% of all colorectal carcinomas. It is an independent prognostic factor associated with less favorable outcome. This aggressiveness is mainly due to the intrinsic biology of these tumors. Here is an overview of the literature r...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章,评审

    doi:10.1016/j.bulcan.2015.07.005

    authors: Arifi S,Elmesbahi O,Amarti Riffi A

    更新日期:2015-10-01 00:00:00

  • [Loco-regional treatments of the metastatic sites for patients with pauci-metastatic cutaneous melanoma (without brain metastasis): French national guidelines].

    abstract:INTRODUCTION:The last years are marked by the emergence of new molecules for the treatment of metastatic cutaneous melanoma with a significant benefit on the survival. Besides, some techniques are in development for the loco-regional treatment of the metastatic sites, bringing new therapeutic perspectives. However, the...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章,实务指引

    doi:10.1684/bdc.2013.1868

    authors: Sassolas B,Mourrégot A,Thariat J,Tiffet O,Dygai-Cochet I,Mirabel X,Truc G,Cupissol D,Modiano P,Combemale P,Bedane C,Derrey S,Lamant L,Lubrano V,Siegrist S,Rougé-Bugat MÈ,Mazeau-Woynar V,Verdoni L,Planchamp F,Leccia

    更新日期:2014-01-01 00:00:00

  • [Specificities of carcinomas in adolescents and young adults].

    abstract::Carcinomas are rare tumors of the adolescent-young adult (AYA) with a different spectrum from those of adults. The most common sites outside of the thyroid is the nasopharynx, salivary gland, colon-rectum and ovaries. If nasopharyngeal carcinoma or salivary gland tumors are good prognosis, others are more reserved pro...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章,评审

    doi:10.1016/j.bulcan.2016.11.013

    authors: Fresneau B,Dourthe ME,Jouin A,Laurence V,de Lambert G,Colas C,Coret M,Laprie A,Rebours C,Orbach D,Demoor-Goldschmidt C

    更新日期:2017-03-01 00:00:00

  • [Gliomas and BRCA genes mutations: fortuitous association or imputability?].

    abstract::BRCA is a tumor suppressor gene implicated in the major mechanisms of cellular stability in every type of cell. Its mutations are described in numerous cancers, mainly breast and ovarian in women. It was also found an increase of lifetime risk of pancreas, colon, prostate cancer or lymphoma in men carriers. We report ...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章

    doi:10.1684/bdc.2014.1952

    authors: Girardstein-Boccara L,Mari V,Met-Domestici M,Burel-Vandenbos F,Berthet P,Paquis P,Frenay MP,Lebrun-Frenay C

    更新日期:2014-09-01 00:00:00